Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1

Cancer

Volumn 91, Issue 11, 2001, Pages 2056-2064

  Maruyama, Akiko ^a   Miyamoto, Shingo ^a   Saito, Toshiaki ^a   Kondo, Haruhiko ^a   Baba, Hideo ^a   Tsukamoto, Naoki ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Clinicopathologic factors; Endometrial carcinoma; Family history of cancer; MSH2,MLH1; Multiple primary carcinomas; P53

Indexed keywords

GENE PRODUCT; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASE MISPAIRING; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA; CARRIER PROTEINS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASMS, MULTIPLE PRIMARY; NUCLEAR PROTEINS; PEDIGREE; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035371519     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010601)91:11<2056::AID-CNCR1232>3.0.CO;2-S     Document Type: Article

References (43)

1. Santos MC, Gardner B, Feldman J. Analysis of multiple primary cancers in a single institution. J Surg Oncol 1994;55: 95-9.
2. Tsukuma H, Fujimoto I, Hanai A, Hiyama T, Kitagawa T, Kinoshita N. Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res, 1994;85:339-45.
3. Annegers JF, Malkasian GD Jr. Patterns of other neoplasia in patients with endometrial carcinoma. Cancer 1981;48:856-9.
4. Schwartz Z, Ohel G, Birkenfeld A, Anteby SO, Schenker JG. Second primary malignancy in enodmetrial carcinoma patients. Gynecol Oncol 1985;22:40-5.
5. Re A, Taylor TH, DiSaia PJ, Anton-Culver H. Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population-based case series. Gynecol Oncol 1997;66:255-7.
6. Shoen RE, Weissfeld JL, Kuller LH. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol 1994;89:835-42.
7. Berchuck A, Boyd J. Molecular basis of endometrial cancer. Cancer 1995;76:2034-40.
8. Burton JL, Wells M. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathology 1998;33:297-303.
9. Hakala-Ala-Pietilä T, Mecklin J-P, Forss M, Järvinen H, Lehtovirta P. Endometrial carcinoma in the cancer family syndrome. Cancer 1991;68:1656-9.
10. Lynch HT, Lynch J, Conway T, Watson P, Coleman RL. Familial aggregation of carcinoma of the endometrium. Am J Obstet Gynecol 1994;171:24-7.
11. Suomi R, Hakala-Ala-Pietilä T, Leminen A, Mecklin J-P, Lehtovirta P. Hereditary aspects of endometrial adenocarcinoma. Int J Cancer 1995;62:132-7.
12. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
13. Millar AL, Pal T, Madlensky L, Sherman C, Temple L, Mitri A, et al. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet 1999;8:823-9.
14. Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590-4.
15. Kolodner RD, Hall NR, Lipford J, Kane MF, Morrison PT, Finan PJ, et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal cancer kindred for MLH1 mutations. Cancer Res 1995;55:242-8.
16. Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 1993;71: 1460-3.
17. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. Histological typing of female genital tract tumours. International histological classification of tumours. 2nd ed. Berlin: World Health Organization and Springer-Verlag, 1994.
18. Pal T, Flanders T, Mitchell-Lehman M, MacMillan A, Brunet J-S, Narod SA, et al. Genetic implications of double primary cancers of the colorectum and endometrium. J Med Genet 1998;35:978-84.
19. Warren S, Gates O. Multiple primary malignant tumors -survey of literature and statistical study. Am J Cancer 1932; 16:1358-414.
20. Vasen HFA, Mecklin J-P, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
21. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
22. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, et al. Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 1994;58:14-9.
23. Inoue M, Fujita M, Enomoto T, Monden M, Morimoto H, Shimano T, et al. Immunohistochemical analysis of p53 in gynecologic tumors. Am J Clin Pathol 1994;102:665-70.
24. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
25. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-40.
26. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-8.
27. Dietmaier W, Wallinger S, Bocker T, Kullman F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair expression. Cancer Res 1997;57:4749-56.
28. Katabuchi H, Rees B, Lambers AR, Ronnett BM, Blazes MS, Leach FS, et al. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 1995;55:5556-60.
29. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-11.
30. Salvesen HB, MacDonald N, Ryan A, Iversen OE, Jacobs IJ, Akslen IA, et al. Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 2000;6:3607-13.
31. Boland CR, Thibodeau SN, Hamilton SR, SidranskyD, Eshleman JR, Burt RW, et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
32. Jovanovic AS, Boynton KA, Mutter GL. Uteri of woman with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancer, some with microsatellite instability. Cancer Res 1995;56:1917-21.
33. Mutter GL, Boynton KA, Faquin WC, Ruiz RE, Jovanovic AS. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res 1996;56:4483-6.
34. Kihara T, Fujioka T, Hamada K, Kito K, Takahashi A, Tsukayama C, et al. Association of replication error positive phenotype with lymphocyte infiltration in endometrial cancers. Jpn J Cancer Res 1998;89:895-902.
35. Levine RL, Cargile CB, Blazes MS, Rees B, Kurman RJ, Ellenson LH. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrial carcinoma. Cancer Res 1998;58:3254-8.
36. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J, et al. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993;53:5100-3.
37. Burks RT, Theodore DK, Cho KR, Hedrick L. Microsatellite instability in endometrial carcinoma. Oncogene 1994;9:1163-6.
38. Heiland A, Borresen-Dale AL, Peltomaki P, Hektoen M, Kristensen GB, Nesland JM, et al. Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 1997;70: 499-501.
39. Horii A, Han H-J, Shimada M, Yanagisawa A, Kato Y, Ohta H, et al. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res 1994;54:3373-5.
40. Brown SR, Finan PJ, Hall NR, Bishop DT. Incidence of DNA replication errors in patients with multiple primary cancers. Dis Colon Rectum 1998;41:765-9.
41. Lim PC, Tester D, Cliby W, Ziesmer SC, Roche PC, Hartmann L, et al. Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability. Clin Cancer Res 1996;2:1907-11.
42. Simpkins SB, Swisher EM, Mutch DG, Gersell DJ, Fishel R, Goodfellow PJ. MLH1 promoter methylation correlates with MSI-positive phenotype and lack of gene expression in sporadic endometrial cancers [abstract 199]. Am J Hum Genet 1998;63:A38.
43. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, et al. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 1994;54:4667-70.